UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 330

Sortiert nach

Immunogenicity and loss of response to TNF inhibitors: implications for rheumatoid arthritis treatment

Nature reviews. Rheumatology, 2017-12, Vol.13 (12), p.707

2017

Volltextzugriff (PDF)

Advances in rheumatology: new targeted therapeutics

Arthritis research & therapy, 2011-05, Vol.13 Suppl 1 (S1), p.S5-S5, Article S5

2011

Volltextzugriff (PDF)

80 milestones in rheumatology from 80 years- III. 1980-2000

Zeitschrift für Rheumatologie, 2021-08, Vol.80 (6), p.515-527

2021

Volltextzugriff (PDF)

Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE

The Journal of experimental medicine, 2008-12, Vol.205 (13), p.3007-3018

2008

Volltextzugriff (PDF)

The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis

Nature medicine, 2008-07, Vol.14 (7), p.748-755

2008

Volltextzugriff (PDF)

Emerging Therapies for Rheumatoid Arthritis

Rheumatology and therapy., 2016-06, Vol.3 (1), p.31-42

Kalden, Joachim. R.

2016

Volltextzugriff (PDF)

Unmet need in rheumatology: reports from the Targeted Therapies meeting 2019

Annals of the rheumatic diseases, 2020-01, Vol.79 (1), p.88

2020

Volltextzugriff (PDF)

Immunology in Germany: 50 th Anniversary of the German Society for Immunology (DGfI)

European journal of immunology, 2017-12, Vol.47 (12), p.2012-2016

2017

Volltextzugriff (PDF)

Stress of different types increases the proinflammatory load in rheumatoid arthritis

Arthritis research & therapy, 2009-01, Vol.11 (3), p.114-114

2009

Volltextzugriff (PDF)

The Evolution of Human Anti-Double-Stranded DNA Autoantibodies

Proceedings of the National Academy of Sciences - PNAS, 2005-06, Vol.102 (26), p.9258-9263

2005

Volltextzugriff (PDF)

Immunology in Germany: 50th Anniversary of the German Society for Immunology (DGfI)

European journal of immunology, 2017-12, Vol.47 (12), p.2012-2016

2017

Volltextzugriff (PDF)

Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis

The New England journal of medicine, 2000-11, Vol.343 (22), p.1594-1602

2000

Volltextzugriff (PDF)

Defective suppressor function of human CD4+ CD25+ regulatory T cells in autoimmune polyglandular syndrome type II

The Journal of experimental medicine, 2004-05, Vol.199 (9), p.1285-1291

2004

Volltextzugriff (PDF)

The IL-4 receptor alpha-chain-binding cytokines, IL-4 and IL-13, induce forkhead box P3-expressing CD25+CD4+ regulatory T cells from CD25-CD4+ precursors

The Journal of immunology (1950), 2005-11, Vol.175 (9), p.6107-6116

2005

Volltextzugriff (PDF)

Anti-TNF therapy: what have we learned in 12 years?

Arthritis research & therapy, 2011-05, Vol.13 Suppl 1 (S1), p.S1-S1, Article S1

Kalden, Joachim R

2011

Volltextzugriff (PDF)

Two-year efficacy and safety of infliximab treatment in patients with active psoriatic arthritis: findings of the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT)

Journal of rheumatology, 2008-05, Vol.35 (5), p.869

2008

Volltextzugriff (PDF)

Advances in targeted therapy

Rheumatology (Oxford, England), 2016-12, Vol.55 (suppl 2), p.ii1-ii2

2016

Volltextzugriff (PDF)

Impaired clearance of dying cells in systemic lupus erythematosus

Autoimmunity reviews, 2005-04, Vol.4 (4), p.189-194

2005

Volltextzugriff (PDF)

Hollow Zinc Oxide Mesocrystals from an Ionic Liquid Precursor (ILP)

Advanced materials (Weinheim), 2008-04, Vol.20 (7), p.1279-1285

2008

Volltextzugriff (PDF)

Prevention of gonadal toxicity and preservation of gonadal function and fertility in young women with systemic lupus erythematosus treated by cyclophosphamide: The PREGO-Study

Autoimmunity reviews, 2006-04, Vol.5 (4), p.269-272

2006

Volltextzugriff (PDF)

Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial

The Lancet (British edition), 1999-01, Vol.353 (9149), p.259-266

1999

Volltextzugriff (PDF)

Inhibition of phosphatidylserine recognition heightens the immunogenicity of irradiated lymphoma cells in vivo

The Journal of experimental medicine, 2004-11, Vol.200 (9), p.1157-1165

2004

Volltextzugriff (PDF)

The unmet need in rheumatology: reports from the Targeted Therapies meeting 2016

Clinical and experimental rheumatology, 2016-07, Vol.34 (4 Suppl 98), p.69

2016

Volltextzugriff (PDF)

Physical function and health related quality of life: analysis of 2-year data from randomized, controlled studies of leflunomide, sulfasalazine, or methotrexate in patients with active rheumatoid arthritis

Journal of rheumatology, 2005-04, Vol.32 (4), p.590

2005

Volltextzugriff (PDF)

1 – 25 von 330

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(219)
Mit Volltextzugriff
(288)

Publikationsform

Artikel
(302)
Buchkapitel
(25)
Bücher
(3)

Sprache

Englisch
(316)
Japanisch
(45)
Deutsch
(13)

Erscheinungsjahr

n.n

Thema

Humans
(206)
Science & Technology
(200)
Life Sciences & Biomedicine
(191)
Biological And Medical Sciences
(114)
Medical Sciences
(97)
Rheumatology
(85)
Immunology
(72)
Female
(68)
Male
(59)
Adult
(51)
Animals
(51)
Middle Aged
(50)
Diseases Of The Osteoarticular System
(40)
Rheumatoid Arthritis
(38)
Inflammatory Joint Diseases
(33)
Antibodies, Monoclonal - Therapeutic Use
(32)
Apoptosis
(29)
Mice
(29)
Aged
(28)
Arthritis, Rheumatoid - Drug Therapy
(28)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Immunogenicity and loss of response to TNF inhibitors: implications for rheumatoid arthritis treatment

Advances in rheumatology: new targeted therapeutics

80 milestones in rheumatology from 80 years- III. 1980-2000

Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE

The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis

Emerging Therapies for Rheumatoid Arthritis

Unmet need in rheumatology: reports from the Targeted Therapies meeting 2019

Immunology in Germany: 50 th Anniversary of the German Society for Immunology (DGfI)

Stress of different types increases the proinflammatory load in rheumatoid arthritis

The Evolution of Human Anti-Double-Stranded DNA Autoantibodies

Immunology in Germany: 50th Anniversary of the German Society for Immunology (DGfI)

Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis

Defective suppressor function of human CD4+ CD25+ regulatory T cells in autoimmune polyglandular syndrome type II

The IL-4 receptor alpha-chain-binding cytokines, IL-4 and IL-13, induce forkhead box P3-expressing CD25+CD4+ regulatory T cells from CD25-CD4+ precursors

Anti-TNF therapy: what have we learned in 12 years?

Two-year efficacy and safety of infliximab treatment in patients with active psoriatic arthritis: findings of the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT)

Advances in targeted therapy

Impaired clearance of dying cells in systemic lupus erythematosus

Patient global assessment in psoriatic arthritis: a multicenter GRAPPA and OMERACT study

Hollow Zinc Oxide Mesocrystals from an Ionic Liquid Precursor (ILP)

Prevention of gonadal toxicity and preservation of gonadal function and fertility in young women with systemic lupus erythematosus treated by cyclophosphamide: The PREGO-Study

Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial

Inhibition of phosphatidylserine recognition heightens the immunogenicity of irradiated lymphoma cells in vivo

The unmet need in rheumatology: reports from the Targeted Therapies meeting 2016

Physical function and health related quality of life: analysis of 2-year data from randomized, controlled studies of leflunomide, sulfasalazine, or methotrexate in patients with active rheumatoid arthritis

Suchergebnisse filtern